Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S491000, C546S134000, C546S268100, C546S270700, C544S106000, C544S336000
Reexamination Certificate
active
06900237
ABSTRACT:
The present invention relates to novel cysteine protease inhibitors; the pharmaceutically acceptable salts and N-oxides thereof; their uses as therapeutic agents and the methods of their making.
REFERENCES:
patent: WO 96/30353 (1996-10-01), None
patent: WO 98/47523 (1998-10-01), None
patent: WO 00/48993 (2000-08-01), None
patent: WO 00/55144 (2000-09-01), None
Axys Pharmaceuticals Inc.
Bansal Rekha
Celera, an Applera Corporation Business
Shameem Golam M M
Wade Janice V.
LandOfFree
Sulfonamide compounds as protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide compounds as protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide compounds as protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383756